TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NUVB

Nuvation Bio Inc

Healthcare · Biotechnology

5.70$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NUVB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.0% 99.1% 99.5% 99.5% 99.3% 99.2% 97.3% 96.1%
87.3% 2.9% 13.4% 17.1% 15.0% 6.9% 6.6% 27.6%
87.3% 98.3% 97.3% 98.6% 98.3% 98.3% 93.0% 89.0%
– 0.7% 0.5% 0.4% 0.4% 0.6% 3.0% 3.3%
– – 1.3% 82.9% – – 0.0% 1.9%
– 0.5% 0.3% 0.5% 0.1% – – –
– – – – – – 0.9% 1.9%
570.9% 2.6% 3.0% 3.9% 2.5% 2.6% 14.2% 48.6%
570.9% 2.6% 3.0% 2.2% 2.0% 2.2% 10.8% 13.8%
379.7% – – 0.1% 0.2% 0.3% 1.5% 1.3%
52.5% 1.7% 1.0% 0.5% 0.3% 0.4% 1.2% 1.6%
– – – – – – – 7.9%
-470.9% 97.4% 97.0% 96.1% 97.5% 97.4% 85.8% 51.4%
-470.9% -28.4% -34.2% -21.0% -39.7% -55.2% -168.5% -187.5%
116,288.6% 170.9% 98.1% 25.5% 32.2% 35.2% 49.7% 57.4%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?